Spotlight on PBMs: 2018 Annual Review

$249.00

Spotlight on PBMs: 2018 Annual Review. AMI’s 2018 Annual Review of Pharmacy Benefit Managers (PBMs) finds participants under increasing scrutiny for the role they play in the high prices of drugs in today’s market.

Consolidation in the PBM market has resulted in a small number of larger players that are able to leverage their size for more negotiating power with insurers and drug makers. PBMs, commonly referred to middlemen in today’s market, have been able to obtain significant influence over pricing and competition.

Current PBMs are scrambling to develop strategies to succeed, health plans are creating in-house PBMs, IT based companies are eyeing small niches to compete, and new entries, especially Amazon, are beginning to surface.